|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM074101072 |
| 003 |
DE-627 |
| 005 |
20250129055756.0 |
| 007 |
tu |
| 008 |
231222s1980 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed25n0247.xml
|
| 035 |
|
|
|a (DE-627)NLM074101072
|
| 035 |
|
|
|a (NLM)7433473
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Kitamura, S
|e verfasserin
|4 aut
|
| 245 |
1 |
4 |
|a The treatment of asthmatic patients using an alpha-adrenergic receptor blocking agent, co-dergocrine mesylate ('Hydergine')
|
| 264 |
|
1 |
|c 1980
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 29.01.1981
|
| 500 |
|
|
|a Date Revised 17.11.2004
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a A study was carried out in 40 patients with bronchial asthma to assess the therapeutic effect of co-dergocrine ('Hydergine'), an alpha-adrenergic receptor blocking agent, when added to their standard treatment with a beta-adrenergic receptor stimulant and aminophylline. Co-dergocrine administration (3 to 6 mg per day) brought about marked improvement in 25% and an improvement in 55% of the patients. The results suggest that co-dergocrine could be a useful drug when combined with other bronchodilators in the treatment of bronchial asthma
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Bronchodilator Agents
|2 NLM
|
| 650 |
|
7 |
|a Dihydroergotoxine
|2 NLM
|
| 650 |
|
7 |
|a 11032-41-0
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
|d 1995
|g 2(1980), 5 vom: 08., Seite 330-6
|w (DE-627)NLM023961570
|
| 773 |
1 |
8 |
|g volume:2
|g year:1980
|g number:5
|g day:08
|g pages:330-6
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 2
|j 1980
|e 5
|b 08
|h 330-6
|